Hypokalemia induced myopathy as first manifestation of primary hyperaldosteronism - An elderly patient with unilateral adrenal hyperplasia: A case report

Cases Journal

Volumn 2, Issue 7, 2009, Pages

  Kotsaftis, Panagiotis ^a   Savopoulos, Christos ^a   Agapakis, Dimitrios ^a   Ntaios, George ^a   Tzioufa, Valentini ^a   Papadopoulos, Vasilios ^a   Fahantidis, Epaminondas ^a   Hatzitolios, Apostolos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; IRBESARTAN; POTASSIUM; SPIRONOLACTONE;

ADRENAL HYPERPLASIA; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOKALEMIA; MALE; METABOLIC ALKALOSIS; MUSCLE WEAKNESS; MYOPATHY; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; RHABDOMYOLYSIS; SINUS RHYTHM;

EID: 77953448216     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.4076/1757-1626-2-6813     Document Type: Article

References (16)

1. Young WF Jr: Primary aldosteronism-treatment options. Growth Hormone & IGF Research 2003, 13:102-108.
2. Mattsson C, Young WF Jr: Primary aldosteronism: diagnostic and treatment strategies. Nature Clin Pract Nephrol 2006, 2:198-208.
3. Katayama Y, Takata N, Tamura T, Yamamoto A, Hirata F, Yasuda H, Matsukuma S, Daido Y, Sasano H: A case of primary aldosteronism due to unilateral adrenal hypeplasia. Hypertens Res 2005, 28:379-384.
4. Pekarske SL, Herold DA: Primary aldosteronism in a patient with an aldosterone-producing adenoma. Clin Chem 1993, 39:1729-1733.
5. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Zamboulis Ch: Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008, 371:1921-1926.
6. Goh BK, Tan YH, Chang KT, Enq PH, Yip SK, Chenq CW: Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases. World J Surg 2007, 31:72-79.
7. Huang YY, Hsu BRS, Tsai JS: Paralytic myopathy-a leading clinical presentation for primary aldosteronism in Taiwan. J Clin Endocrinol Metab 1996, 81:4038-4041.
8. Crawhall JC, Tolis G, Roy D: Elevation of serum creatine kinase in severe hypokalemic hyperaldosteronism. Clin Biochem 1976, 9:237-240.
9. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr: Prevelance of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000, 85:2854-2859.
10. Hatzitolios A, Delivoria C, Karabatsu S, Savopoulos C, Karamuzia M, Tsatidis R, Tataridis A, Kartavenko IM: A case of inactive adrenal node that transformed to adenoma with manifestations of primary hyperaldosteronism in a patient with essential hypertension. Klin Med 2004, 82:67-68.
11. Karagiannis A, Tziomalos K, Kakafika A, Harsoulis F, Zamboulis Ch: Paralysis as first manifestation of primary aldosteronism. Nephrol Dial Transplant 2004, 19:2418-2424.
12. Young WF Jr, Hogan MJ, Klee GG, Grant CS, Van Heerden JA: Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc 1990, 65:96-110.
13. Tamura Y, Adachi JI, Chiba Y, Mori S, Takeda K, Kasuya Y, Murayama T, Sawabe M, Sasano H, Araki A, Ito H, Horiuchi T: Primary aldosteronism due to unilateral adrenal microadenoma in an elderly patient: efficacy of selective adrenal venous sampling. Intern Med 2008, 47:37-42.
14. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T: Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general out patient clinic in Japan. Hypertens Res 2004, 27:193-202.
15. Chen SY, Shen SJ, Chou CW, Yang CY, Cheng HM: Primary aldosteronism caused by unilateral adrenal hyperplasia: rethinking the accuracy of imaging studies. J Chin Med Assoc 2006, 69:125-129.
16. Toniato A, Bernante P, Rossi GP, Pelizzo MR: The role of adrenal venous sampling in the surgical management of primary aldosteronism. World J Surg 2006, 30:624-627.